Zoekresultaten - 4 results

Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 framework.

cervical cancer screening should be clinically validated according to international criteria. OncoPredict HPV ® Screening (SCR) is a partial genotyping multiplex real-time PCR assay targeting E6 / E7 genes ...

Triage of ASC-H: A meta-analysis of the accuracy of high-risk HPV testing and other markers to detect cervical precancer.

(specificity ratio, 1.69) to HC2 for CIN2 +. Testing for paired box 1 gene methylation (only 1 study) showed a superior specificity of 95% (specificity ratio, 2.08). The average pretest risk was 34% for CIN2 ...

Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials.

genes and showed that the selected phages 14/1, PNM and ISP are close relatives of respectively F8, phiKMV and phage G1. The bacteriophage cocktail is currently being evaluated in a pilot clinical study ...

Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.

and participating in cervical cancer screening, were assessed cytologically and virologically with a multiplex real-time PCR using primers targeting the E6 / E7 genes of 16 HPV types. Correlations of ...

QR code

QR code for this page URL